- Lab Tests
- Health Corner
VOMIOF 8MG TABLET contains Ondansetron, which belongs to a group of medicines called Anti-emetics. It is used to treat and prevent nausea and vomiting induced by chemotherapy or radiotherapy. VOMIOF 8MG TABLET is also used after surgeries (operation) to prevent nausea and vomiting.
Before taking VOMIOF 8MG TABLET, inform your doctor if you have severe constipation, heart or liver problems, imbalance with the levels of salts in the blood, such as potassium, sodium and magnesium or if you have been scheduled for any surgery.
VOMIOF 8MG TABLET is not recommended for use during pregnancy. This medicine may pass through the breast milk hence it is not recommended during breastfeeding. Consult your doctor before taking this medicine.
The dose of VOMIOF 8MG TABLET will depends on the age, body weight and disease condition of your child. Dosage adjustment is not required in elderly patients, hence consult your doctor before taking VOMIOF 8MG TABLET.
The most common side effects of taking VOMIOF 8MG TABLET includes headache, flushing and constipation. Consult your doctor if any of these above symptoms gets worse.
VOMIOF 8MG TABLET is a serotonin 5-HT3 receptor antagonist (specific chemical receptor) which works by blocking serotonin receptors in CTZ chemoreceptor trigger zone (zone in the brain that is responsible for causing nausea and vomiting).
Take VOMIOF 8MG TABLET as advised by your physician. It can be taken with or without food.
For Tablet, Capsule: Swallow VOMIOF 8MG TABLET with a glass of water. Do not crush or chew the medicine.
For Dispersible Tablet: Disperse the medicine in the specified quantity of water as mentioned in the label. Consume the medicine immediately after reconstitution.
Your doctor will decide the correct dose and duration of therapy for you depending upon your age, body weight and severity of the infection.
Stop taking VOMIOF 8MG TABLET and contact your doctor if you experience any of the following side effects:
Take rest. Have good amount of sleep. Have a balanced diet and at regular intervals. Add more fluids to your diet. Drink plenty of water to replenish water stores.
Eat plenty of fibre rich foods such as fresh fruits, vegetables, and cereals. Drink water and exercise regularly. Contact your doctor if constipation persists.
Lie down until the dizziness passes and get up slowly. Do not bend down suddenly. Get a lot of rest. Walk slowly and carefully. Take plenty of fluids. Avoid drinking coffee, alcohol or smoking. Consult your doctor if the condition persists for long or gets worsened.
VOMIOF 8MG TABLET is generally not recommended for use during pregnancy unless considered clearly necessary. Consult your doctor before taking VOMIOF 8MG TABLET.
VOMIOF 8MG TABLET is not recommended for use in breastfeeding women as it may pass through the breast milk. Consult your doctor before taking VOMIOF 8MG TABLET.
Do not drive or operate any machines if you feel dizzy or uneasy after taking VOMIOF 8MG TABLET.
VOMIOF 8MG TABLET should be used with caution in patients with liver problems. Consult your doctor before taking VOMIOF 8MG TABLET.
Do not take VOMIOF 8MG TABLET if you are allergic to ondansetron, granisetron or palonosetron or to any other ingredients of this medicine.
VOMIOF 8MG TABLET should be used with caution in patients with heart diseases such as uneven heartbeats (arrhythmias) or congestive heart failure. Consult your doctor before taking VOMIOF 8MG TABLET.
Before taking VOMIOF 8MG TABLET, inform your doctor if you:
Use in pediatrics:
Your doctor will give the right dose of VOMIOF 8MG TABLET depends on your child’s age, body weight and disease condition. Consult your doctor before taking VOMIOF 8MG TABLET.
Use in geriatrics:
Dosage adjustment is not required in elderly patients, hence consult your doctor before taking VOMIOF 8MG TABLET.
A. Drug-Drug Interactions:
Before taking VOMIOF 8MG TABLET, inform your doctor, if you are taking any of the following medicine:
If you or anyone else accidentally takes too much of VOMIOF 8MG TABLET, consult your doctor immediately or visit the nearby hospital.
|Pharmacological Category||:||Serotonin antagonist|
|Therapeutic Indication||:||Nausea and Vomiting in patients (undergoing chemotherapy, radiotherapy, surgery)|
|Dosage Forms||:||Tablet, Injection, Dispersible Tablet, Syrup, Suspension, Oral strips, Lozenges, Pastille|
Q: Is VOMIOF 8MG TABLET a chemo drug?
A: No, it is not a chemo drug. It belongs to a group of medicines called serotonin antagonists and used to treat side effects caused due to chemotherapy.
Q: Is VOMIOF 8MG TABLET safe in pregnancy?
A: VOMIOF 8MG TABLET is not recommended for use in pregnancy unless clearly necessary as it is not known whether it may cause harm to the unborn baby. Contact your doctor before taking.
Q: What VOMIOF 8MG TABLET is used for?
A: VOMIOF 8MG TABLET is used to treat nausea and vomiting caused by medical treatments like chemotherapy, radiotherapy or surgery.
Q: For how long should you take VOMIOF 8MG TABLET?
A: Your doctor will advise you on how long you should continue to take VOMIOF 8MG TABLET. Consult your doctor from time to time to review your treatment and assess your symptoms.
Q: What happens if you take more VOMIOF 8MG TABLET than your required dose?
A: If you or anyone else accidentally takes too much of VOMIOF 8MG TABLET, consult your doctor immediately or visit the nearby hospital.
Q: What side effects are seen with VOMIOF 8MG TABLET?
A: The most common side effects of taking VOMIOF 8MG TABLET are headaches, flushing (feeling of warmth), constipation. Consult your doctor if above side effects got worse.
1. KD. Tripathi. Section 11, Gastrointestinal Drugs. Essentials of medical pharmacology. Seventh edition. 2013. Page – 661.
2. LTS Lohmann Therapie-Systeme AG Lohmannstrasse. Andernach GERMANY [Revised April 2022] [Accessed on 29 September 2022] https://www.medicines.org.uk/emc/files/pil.9595.pdf
3. Koland M, Sandeep V, Charyulu N. Fast Dissolving Sublingual Films of Ondansetron Hydrochloride: Effect of Additives on in vitro Drug Release and Mucosal Permeation. J Young Pharm. 2010 Jul;2(3):216-22. [Accessed on 29 September 2022] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2964757/
4. Kumria R, Gupta V, Bansal S, Wadhwa J, Nair AB. Oral buccoadhesive films of ondansetron: Development and evaluation. Int J Pharm Investig. 2013 Apr;3(2):112-8. [Accessed on 29 September 2022] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757901/
5. Ondansetron Soluble Films. [Accessed on 29 September 2022] https://my.clevelandclinic.org/health/drugs/20819-ondansetron-soluble-films
6. Myoclinic. [Accessed on 29 September 2022] https://www.mayoclinic.org/drugs-supplements/ondansetron-oral-route-oromucosal-route/proper-use/drg-20074421
Written By Dr. Janet.C, Pharm.D
Last updated on 20 Jan 2023 | 06:15 PM(IST)
The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.